KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Free Cash Flow (2017 - 2025)

Johnson & Johnson (JNJ) has disclosed Free Cash Flow for 17 consecutive years, with $5.5 billion as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 1.88% to $5.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.7 billion through Dec 2025, down 0.73% year-over-year, with the annual reading at $19.7 billion for FY2025, 0.73% down from the prior year.
  • Free Cash Flow hit $5.5 billion in Q4 2025 for Johnson & Johnson, down from $8.0 billion in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $8.0 billion in Q3 2025 to a low of $1.7 billion in Q1 2023.
  • Historically, Free Cash Flow has averaged $4.7 billion across 5 years, with a median of $4.6 billion in 2021.
  • Biggest five-year swings in Free Cash Flow: skyrocketed 259.75% in 2023 and later tumbled 39.12% in 2025.
  • Year by year, Free Cash Flow stood at $7.5 billion in 2021, then plummeted by 55.3% to $3.4 billion in 2022, then soared by 86.06% to $6.3 billion in 2023, then dropped by 14.39% to $5.4 billion in 2024, then rose by 1.88% to $5.5 billion in 2025.
  • Business Quant data shows Free Cash Flow for JNJ at $5.5 billion in Q4 2025, $8.0 billion in Q3 2025, and $2.8 billion in Q2 2025.